Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Eran Goldberg is a co-founder and CTO of multiple companies in Israel and Europe. He has extensive experience in R&D management and drug development, specializing in optimizing formulations, establishing production facilities and processes, and enhancing product and manufacturing efficacy under GMP conditions. He holds a PhD in Computational Chemistry from the Weizmann Institute of Science, has co-authored academic articles and patents, and has led protocol development for various clinical trials.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Eran Goldberg's primary investment focus by sector?
- Eran Goldberg has invested in the Health Tech & Life Sciences sector, with Panaxia being a notable company in this area.
- Can you provide details on a recent investment by Eran Goldberg?
- In April 2020, Eran Goldberg participated in a PIPE round for Panaxia, which raised $11.6M.
- What is the typical investment stage for Eran Goldberg?
- Eran Goldberg has participated in a PIPE funding round, indicating an interest in later-stage investments.
- Which portfolio company is highlighted for Eran Goldberg?
- Panaxia, a company focused on medical cannabis products, is a key portfolio company for Eran Goldberg.
- What is the investment range for Eran Goldberg?
- Eran Goldberg's investment range is between $6.3M and $6.3M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Radar intelligence
Patents
| EPO | 6 |
|---|